146 related articles for article (PubMed ID: 35731292)
1. Prior cancer history predicts the worse survival of patients with nasopharyngeal carcinoma.
Yeh CF; Chin YC; Huang WH; Lan MY
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5381-5387. PubMed ID: 35731292
[TBL] [Abstract][Full Text] [Related]
2. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR
Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
[TBL] [Abstract][Full Text] [Related]
3. Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.
Wang L; Wu Z; Xie D; Lv S; Xia L; Su Y
Radiat Oncol; 2020 Jul; 15(1):160. PubMed ID: 32615984
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of chemoradiotherapy in survival of stage Ⅳ nasopharyngeal carcinoma and establishment of a prognostic model.
Luo HD; Xia FJ; Wu JH; Yi B
Oral Oncol; 2022 Aug; 131():105927. PubMed ID: 35679694
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study.
Siti-Azrin AH; Norsa'adah B; Naing NN
BMC Res Notes; 2017 Dec; 10(1):705. PubMed ID: 29212521
[TBL] [Abstract][Full Text] [Related]
6. Survival among subgroups of patients with stage II nasopharyngeal carcinoma.
Huang ST; Su DK
Sci Rep; 2022 Apr; 12(1):7007. PubMed ID: 35488053
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
8. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection.
Liu YP; Li H; You R; Li JB; Liu XK; Yang AK; Guo X; Song M; Zhang Q; Guo ZM; Chen WK; Liu WW; Zou X; Hua YJ; Yang Q; Zhang YN; Sun R; Mo HY; Guo L; Lin AH; Mai HQ; Qian CN; Chen MY
Laryngoscope; 2019 Feb; 129(2):387-395. PubMed ID: 30325027
[TBL] [Abstract][Full Text] [Related]
9. Serum ferritin predicted prognosis in patients with nasopharyngeal carcinoma.
Chen Z; Liang Z; Chen K; Zhang S; Huang X; Wu G; Zhu X
Sci Rep; 2024 Feb; 14(1):4311. PubMed ID: 38383702
[TBL] [Abstract][Full Text] [Related]
10. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.
Liu X; Li X; Jiang N; Lei Y; Tang LL; Chen L; Zhou GQ; Sun Y; Yue D; Guo R; Mao YP; Li WF; Liu LZ; Tian L; Lin AH; Ma J
Cancer; 2014 Jan; 120(1):68-76. PubMed ID: 24114075
[TBL] [Abstract][Full Text] [Related]
12. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.
Zeng X; Liu G; Pan Y; Li Y
J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
[TBL] [Abstract][Full Text] [Related]
15. The role of chemotherapy in the treatment of stage II nasopharyngeal carcinoma: Retrospective analysis of the national cancer database.
Ahmed Z; Kujtan L; Kennedy K; Wood V; Schomas D; Subramanian J
Cancer Med; 2019 Apr; 8(4):1500-1507. PubMed ID: 30790468
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment age and serum lactate dehydrogenase as predictors of synchronous second primary cancer in patients with nasopharyngeal carcinoma.
Yeh CF; Ho CY; Chin YC; Shu CH; Chao YT; Lan MY
Oral Oncol; 2020 Nov; 110():104990. PubMed ID: 32932171
[TBL] [Abstract][Full Text] [Related]
17. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
Huang CL; Guo R; Li JY; Xu C; Mao YP; Tian L; Lin AH; Sun Y; Ma J; Tang LL
Eur Radiol; 2020 Feb; 30(2):816-822. PubMed ID: 31650266
[TBL] [Abstract][Full Text] [Related]
19. CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma.
Chang SL; Chen TJ; Lee YE; Lee SW; Lin LC; He HL
Int J Med Sci; 2018; 15(10):992-998. PubMed ID: 30013440
[No Abstract] [Full Text] [Related]
20. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.
Qiao H; Tan XR; Li H; Li JY; Chen XZ; Li YQ; Li WF; Tang LL; Zhou GQ; Zhang Y; Liang YL; He QM; Zhao Y; Huang SY; Gong S; Li Q; Ye ML; Chen KL; Sun Y; Ma J; Liu N
JAMA Oncol; 2022 Sep; 8(9):1301-1309. PubMed ID: 35834269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
